Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter?

Journal of drugs in dermatology : JDD

Volumn 5, Issue 4, 2006, Pages 317-319

  Yoo, Jane ^a   Reid, David C ^a   Kimball, Alexa B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSAGE FORM; HUMAN; INTRADERMAL DRUG ADMINISTRATION; META ANALYSIS; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; ROSACEA; STATISTICS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; CHRONIC DISEASE; CLINICAL TRIALS, PHASE III; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METRONIDAZOLE; RANDOMIZED CONTROLLED TRIALS; ROSACEA; TREATMENT OUTCOME;

EID: 33748903924     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)